Learn More
Apexbio Technology LLC NLG919, 10mM (in 1mL DMSO). Cas: 1402836-58-1 MFCD: MFCD26142661. Potent IDO pathway inhibitor

Supplier: Apexbio Technology LLC A43735.1
NLG919 is a novel and orally-bioavailable small-molecule inhibitor of indoleamine 2,3-dioxygenase (IDO) pathway, a crucial pathway involved in allergic inflammation that mediates immunosuppressive effects through metabolization of tryptophan (Trp) to kynurenine. Other sizes are available. Please inqury us for quote.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.